In 2006, the U.S. Food and Drug Administration (FDA) approved a version of rHGH called Omnitrope (Sandoz).
2006-ban a US Food and Drug Administration (FDA) jóváhagyta biohasonló változatát a rHGH Omnitrope-ot (Sandoz).)